Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings
Identifieur interne : 004C35 ( Main/Exploration ); précédent : 004C34; suivant : 004C36Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings
Auteurs : David Vlahov [États-Unis] ; Angela M. Robertson ; Steffanie A. StrathdeeSource :
- Clinical Infectious Diseases [ 1058-4838 ] ; 2010-05-15.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- complications : Substance Abuse, Intravenous.
- epidemiology : HIV Infections.
- methods : Communicable Disease Control.
- prevention & control : HIV Infections.
- transmission : HIV Infections.
- Drug Users, Humans.
Abstract
Injection drug use contributes to considerable global morbidity and mortality associated with human immunodeficiency virus (HIV) infection and AIDS and other infections due to blood-borne pathogens through the direct sharing of needles, syringes, and other injection equipment. Of ∼16 million injection drug users (IDUs) worldwide, an estimated 3 million are HIV infected. The prevalence of HIV infection among IDUs is high in many countries in Asia and eastern Europe and could exacerbate the HIV epidemic in sub-Saharan Africa. This review summarizes important components of a comprehensive program for prevention of HIV infection in IDUs, including unrestricted legal access to sterile syringes through needle exchange programs and enhanced pharmacy services, treatment for opioid dependence (ie, methadone and buprenorphine treatment), behavioral interventions, and identification and treatment of noninjection drug and alcohol use, which accounts for increased sexual transmission of HIV. Evidence supports the effectiveness of harm-reduction programs over punitive drug-control policies.
Url:
- https://api.istex.fr/document/AB56510A87203AE1A53B15153653C4D606C37EED/fulltext/pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114556
DOI: 10.1086/651482
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003821
- to stream Istex, to step Curation: 003821
- to stream Istex, to step Checkpoint: 000E05
- to stream Pmc, to step Corpus: 001211
- to stream Pmc, to step Curation: 001210
- to stream Pmc, to step Checkpoint: 002470
- to stream PubMed, to step Corpus: 000417
- to stream PubMed, to step Curation: 000417
- to stream PubMed, to step Checkpoint: 000417
- to stream Ncbi, to step Merge: 000B71
- to stream Ncbi, to step Curation: 000B71
- to stream Ncbi, to step Checkpoint: 000B71
- to stream Main, to step Merge: 004C92
- to stream Main, to step Curation: 004C35
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings</title>
<author><name sortKey="Vlahov, David" sort="Vlahov, David" uniqKey="Vlahov D" first="David" last="Vlahov">David Vlahov</name>
</author>
<author><name sortKey="Robertson, Angela M" sort="Robertson, Angela M" uniqKey="Robertson A" first="Angela M." last="Robertson">Angela M. Robertson</name>
</author>
<author><name sortKey="Strathdee, Steffanie A" sort="Strathdee, Steffanie A" uniqKey="Strathdee S" first="Steffanie A." last="Strathdee">Steffanie A. Strathdee</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:AB56510A87203AE1A53B15153653C4D606C37EED</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1086/651482</idno>
<idno type="url">https://api.istex.fr/document/AB56510A87203AE1A53B15153653C4D606C37EED/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003821</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003821</idno>
<idno type="wicri:Area/Istex/Curation">003821</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E05</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E05</idno>
<idno type="wicri:doubleKey">1058-4838:2010:Vlahov D:prevention:of:hiv</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114556</idno>
<idno type="RBID">PMC:3114556</idno>
<idno type="wicri:Area/Pmc/Corpus">001211</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001211</idno>
<idno type="wicri:Area/Pmc/Curation">001210</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001210</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002470</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002470</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">000417</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000417</idno>
<idno type="wicri:Area/PubMed/Curation">000417</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000417</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000417</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000417</idno>
<idno type="wicri:Area/Ncbi/Merge">000B71</idno>
<idno type="wicri:Area/Ncbi/Curation">000B71</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B71</idno>
<idno type="wicri:doubleKey">1058-4838:2010:Vlahov D:prevention:of:hiv</idno>
<idno type="wicri:Area/Main/Merge">004C92</idno>
<idno type="wicri:Area/Main/Curation">004C35</idno>
<idno type="wicri:Area/Main/Exploration">004C35</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings</title>
<author><name sortKey="Vlahov, David" sort="Vlahov, David" uniqKey="Vlahov D" first="David" last="Vlahov">David Vlahov</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Joseph L. Mailman School of Public Health, Columbia University, New York</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
<affiliation></affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Robertson, Angela M" sort="Robertson, Angela M" uniqKey="Robertson A" first="Angela M." last="Robertson">Angela M. Robertson</name>
<affiliation><wicri:noCountry code="subField">Jolla</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Strathdee, Steffanie A" sort="Strathdee, Steffanie A" uniqKey="Strathdee S" first="Steffanie A." last="Strathdee">Steffanie A. Strathdee</name>
<affiliation><wicri:noCountry code="subField">Jolla</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Clinical Infectious Diseases</title>
<title level="j" type="abbrev">Clinical Infectious Diseases</title>
<idno type="ISSN">1058-4838</idno>
<idno type="eISSN">1537-6591</idno>
<imprint><publisher>The University of Chicago Press</publisher>
<date type="published" when="2010-05-15">2010-05-15</date>
<biblScope unit="volume">50</biblScope>
<biblScope unit="issue">Supplement_3</biblScope>
<biblScope unit="page" from="S114">S114</biblScope>
<biblScope unit="page" to="S121">S121</biblScope>
</imprint>
<idno type="ISSN">1058-4838</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1058-4838</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Communicable Disease Control (methods)</term>
<term>Drug Users</term>
<term>HIV Infections (epidemiology)</term>
<term>HIV Infections (prevention & control)</term>
<term>HIV Infections (transmission)</term>
<term>Humans</term>
<term>Substance Abuse, Intravenous (complications)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Contrôle des maladies contagieuses ()</term>
<term>Humains</term>
<term>Infections à VIH ()</term>
<term>Infections à VIH (transmission)</term>
<term>Infections à VIH (épidémiologie)</term>
<term>Toxicomanie intraveineuse ()</term>
<term>Usagers de drogues</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Substance Abuse, Intravenous</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Communicable Disease Control</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Users</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Contrôle des maladies contagieuses</term>
<term>Humains</term>
<term>Infections à VIH</term>
<term>Toxicomanie intraveineuse</term>
<term>Usagers de drogues</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Injection drug use contributes to considerable global morbidity and mortality associated with human immunodeficiency virus (HIV) infection and AIDS and other infections due to blood-borne pathogens through the direct sharing of needles, syringes, and other injection equipment. Of ∼16 million injection drug users (IDUs) worldwide, an estimated 3 million are HIV infected. The prevalence of HIV infection among IDUs is high in many countries in Asia and eastern Europe and could exacerbate the HIV epidemic in sub-Saharan Africa. This review summarizes important components of a comprehensive program for prevention of HIV infection in IDUs, including unrestricted legal access to sterile syringes through needle exchange programs and enhanced pharmacy services, treatment for opioid dependence (ie, methadone and buprenorphine treatment), behavioral interventions, and identification and treatment of noninjection drug and alcohol use, which accounts for increased sexual transmission of HIV. Evidence supports the effectiveness of harm-reduction programs over punitive drug-control policies.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>État de New York</li>
</region>
</list>
<tree><noCountry><name sortKey="Robertson, Angela M" sort="Robertson, Angela M" uniqKey="Robertson A" first="Angela M." last="Robertson">Angela M. Robertson</name>
<name sortKey="Strathdee, Steffanie A" sort="Strathdee, Steffanie A" uniqKey="Strathdee S" first="Steffanie A." last="Strathdee">Steffanie A. Strathdee</name>
</noCountry>
<country name="États-Unis"><region name="État de New York"><name sortKey="Vlahov, David" sort="Vlahov, David" uniqKey="Vlahov D" first="David" last="Vlahov">David Vlahov</name>
</region>
<name sortKey="Vlahov, David" sort="Vlahov, David" uniqKey="Vlahov D" first="David" last="Vlahov">David Vlahov</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C35 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004C35 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaSubSaharaV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:AB56510A87203AE1A53B15153653C4D606C37EED |texte= Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings }}
![]() | This area was generated with Dilib version V0.6.32. | ![]() |